Hengstberger Symposium – Update on antimicrobial research
The Hengstberger Symposium "Update on antimicrobial research: Joint struggle against the silent pandemic" will take place from March 17-19, 2023, in Heidelberg, Germany.
This event will be organized by Jun.-Prof. Dr. Philipp Uhl and Dr. Florian Umstätter from the University of Heidelberg, Germany.
The possibility of treating bacterial infections with antibiotics represents an important milestone in medical history. Less than 150 years ago, a seemingly harmless injury often led to serious health problems or even death due to a lack of serious treatment options. Nowadays, bacterial infections can fortunately be treated with a wide range of different antibiotics. However, accelerated by excessive or incorrect use of these agents, more and more bacterial pathogens are developing resistance to many of the therapeutic agents available on the market. This is therefore referred to as a "silent pandemic". To prevent a post-antibiotic era, research and development of new antibacterial substances is more important than ever. Despite this high need for innovation, industrial research has largely withdrawn from antibiotics research, primarily for economic reasons. This field of research thus remains largely in the academic environment. Due to the complexity of the development of new active substances, academic research is dependent on well-functioning cooperations and adequate funding opportunities.
In this context, phospholipids also play a role that should not be underestimated, as they can help to encapsulate antimicrobially active substances and transport them to their site of action or protect them from undesirable degradation.
For more information, please visit the Hengstberger Symposium homepage.
"Internationales Wissenschaftsforum Heidelberg" (IWH)
Hauptstrasse 242, 69117 Heidelberg, Germany,
Friday, March 17
Prof. Dr. Axel Helmstädter, opening talk
Dr. Armin Bauer, Antibiotic development in an industrial setting
Pharmaceutical Biology, Speeding up antimicrobial compound evaluation
Saturday, March 18
Prof. Dr. Antti Poso, Early drug discovery efforts and antimicrobial research: systematic lead finding with serendipitous flavor
Pharmaceutical Technology, How to overcome formulation difficulties in antibiotic development?
Pharmaceutical Chemistry, Small scale synthesis of novel antibiotic compounds - part I
Sunday, March 19
Usha Lamichhane, Global AMR R&D Hub
Pharmaceutical Chemistry, Small scale synthesis of novel antibiotic compounds - part II
Prof. Dr. Klaus-Peter Koller, Third-party funding in antibiotic research